Giants’ Mota Appeals 100-Game MLB Ban for Second Drug Violation

San Francisco Giants relief pitcher Guillermo Mota will file an appeal after receiving a 100-game suspension from Major League Baseball for a second violation of the sport’s drug policy.

Mota, 38, tested positive for clenbuterol, a banned performance-enhancing substance, the office of baseball Commissioner Bud Selig said yesterday in an e-mailed release.

“A 100-game suspension for taking a children’s cough medicine that contains trace amounts of a prohibited substance, which is what happened here, is severe and unfair and does not reflect the intention of the Joint Drug Prevention and Treatment Program,” Mota’s agent, Adam Katz, said in an e-mailed statement. “We will appeal it.”

The Giants said in a statement that they were “disappointed” to learn of Mota’s suspension and support baseball’s drug prevention and treatment program.

Mota, who received a 50-game suspension for drug use following the 2006 season, has an 0-1 record with a 5.06 earned run average in nine relief appearances this season. He’s allowed 13 hits and six earned runs in 10 2/3 innings.

Mota is 39-45 with a career 3.92 ERA in 14 seasons with the Montreal Expos, Los Angeles Dodgers, Florida Marlins, Cleveland Indians, New York Mets, Milwaukee Brewers and Giants.

Clenbuterol is a decongestant intended for use by people with breathing disorders. It has been linked to several high- profile doping cases in sports and was the drug that got cyclist Alberto Contador stripped of his victory in the 2010 Tour de France.

To contact the reporter on this story: Eben Novy-Williams in New York at enovywilliam@bloomberg.net

To contact the editor responsible for this story: Michael Sillup at msillup@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.